CD19 and neoplasm: At day 0, samples from most patients presented an extremely high percentage of CD19+ and CD20+ tumor cells (mean 52.9%±28.2% and 45.5%±32.1%, respectively; figure 3C and online supplemental table 3), which progressively decreased at day 7 in either culture conditions (figure 3D).